Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Host-rabies virus protein-protein interactions as druggable antiviral targets.

Lingappa UF, Wu X, Macieik A, Yu SF, Atuegbu A, Corpuz M, Francis J, Nichols C, Calayag A, Shi H, Ellison JA, Harrell EK, Asundi V, Lingappa JR, Prasad MD, Lipkin WI, Dey D, Hurt CR, Lingappa VR, Hansen WJ, Rupprecht CE.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):E861-8. doi: 10.1073/pnas.1210198110. Epub 2013 Feb 12.

2.

Capsid assembly as a point of intervention for novel anti-viral therapeutics.

Lingappa VR, Hurt CR, Garvey E.

Curr Pharm Biotechnol. 2013;14(5):513-23. Review.

PMID:
22429134
3.

Characterization of the mode of action of a potent dengue virus capsid inhibitor.

Scaturro P, Trist IM, Paul D, Kumar A, Acosta EG, Byrd CM, Jordan R, Brancale A, Bartenschlager R.

J Virol. 2014 Oct;88(19):11540-55. doi: 10.1128/JVI.01745-14. Epub 2014 Jul 23.

4.

Viral capsid assembly as a model for protein aggregation diseases: Active processes catalyzed by cellular assembly machines comprising novel drug targets.

Marreiros R, Müller-Schiffmann A, Bader V, Selvarajah S, Dey D, Lingappa VR, Korth C.

Virus Res. 2015 Sep 2;207:155-64. doi: 10.1016/j.virusres.2014.10.003. Epub 2014 Oct 25. Review.

PMID:
25451064
5.

Antiviral drug discovery strategy using combinatorial libraries of structurally constrained peptides.

Real E, Rain JC, Battaglia V, Jallet C, Perrin P, Tordo N, Chrisment P, D'Alayer J, Legrain P, Jacob Y.

J Virol. 2004 Jul;78(14):7410-7.

6.

Evaluation of single and dual siRNAs targeting rabies virus glycoprotein and nucleoprotein genes for inhibition of virus multiplication in vitro.

Meshram CD, Singh NK, Sonwane AA, Pawar SS, Mishra BP, Chaturvedi VK, Saini M, Singh RP, Gupta PK.

Arch Virol. 2013 Nov;158(11):2323-32. doi: 10.1007/s00705-013-1738-z. Epub 2013 Jun 11.

PMID:
23754741
7.
8.

Imaging of the alphavirus capsid protein during virus replication.

Zheng Y, Kielian M.

J Virol. 2013 Sep;87(17):9579-89. doi: 10.1128/JVI.01299-13. Epub 2013 Jun 19.

9.

Small peptide inhibitors disrupt a high-affinity interaction between cytoplasmic dynein and a viral cargo protein.

Hernáez B, Tarragó T, Giralt E, Escribano JM, Alonso C.

J Virol. 2010 Oct;84(20):10792-801. doi: 10.1128/JVI.01168-10. Epub 2010 Aug 4.

10.

The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.

Anwar A, Hosoya T, Leong KM, Onogi H, Okuno Y, Hiramatsu T, Koyama H, Suzuki M, Hagiwara M, Garcia-Blanco MA.

PLoS One. 2011;6(8):e23246. doi: 10.1371/journal.pone.0023246. Epub 2011 Aug 17.

11.

An Aptamer against the Matrix Binding Domain on the Hepatitis B Virus Capsid Impairs Virion Formation.

Orabi A, Bieringer M, Geerlof A, Bruss V.

J Virol. 2015 Sep;89(18):9281-7. doi: 10.1128/JVI.00466-15. Epub 2015 Jul 1.

12.

New horizons for antiviral drug discovery from virus-host protein interaction networks.

de Chassey B, Meyniel-Schicklin L, Aublin-Gex A, André P, Lotteau V.

Curr Opin Virol. 2012 Oct;2(5):606-13. doi: 10.1016/j.coviro.2012.09.001. Epub 2012 Sep 29. Review.

PMID:
23025912
14.

Protection of mice against lethal rabies virus challenge using short interfering RNAs (siRNAs) delivered through lentiviral vector.

Singh NK, Meshram CD, Sonwane AA, Dahiya SS, Pawar SS, Chaturvedi VK, Saini M, Singh RP, Gupta PK.

Mol Biotechnol. 2014 Feb;56(2):91-101. doi: 10.1007/s12033-013-9685-1.

PMID:
23877894
15.

Identification of a host protein essential for assembly of immature HIV-1 capsids.

Zimmerman C, Klein KC, Kiser PK, Singh AR, Firestein BL, Riba SC, Lingappa JR.

Nature. 2002 Jan 3;415(6867):88-92.

PMID:
11780123
16.

Reviewing host proteins of Rhabdoviridae: possible leads for lesser studied viruses.

Guleria A, Kiranmayi M, Sreejith R, Kumar K, Sharma SK, Gupta S.

J Biosci. 2011 Dec;36(5):929-37. Review.

17.

Assembly of immature HIV-1 capsids using a cell-free system.

Lingappa JR, Thielen BK.

Methods Mol Biol. 2009;485:185-95. doi: 10.1007/978-1-59745-170-3_13.

18.

Virus-host interactomes--antiviral drug discovery.

Ma-Lauer Y, Lei J, Hilgenfeld R, von Brunn A.

Curr Opin Virol. 2012 Oct;2(5):614-21. doi: 10.1016/j.coviro.2012.09.003. Review.

PMID:
23057872
19.

An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly.

Stray SJ, Johnson JM, Kopek BG, Zlotnick A.

Nat Biotechnol. 2006 Mar;24(3):358-62. Epub 2006 Feb 12.

PMID:
16474383
20.

Novel phosphoprotein-interacting region in Nipah virus nucleocapsid protein and its involvement in viral replication.

Omi-Furutani M, Yoneda M, Fujita K, Ikeda F, Kai C.

J Virol. 2010 Oct;84(19):9793-9. doi: 10.1128/JVI.00339-10. Epub 2010 Jul 28.

Supplemental Content

Support Center